Literature DB >> 18845632

Expression of peroxisome proliferator-activated receptor-gamma in key neuronal subsets regulating glucose metabolism and energy homeostasis.

David A Sarruf1, Fang Yu, Hong T Nguyen, Diana L Williams, Richard L Printz, Kevin D Niswender, Michael W Schwartz.   

Abstract

In addition to increasing insulin sensitivity and adipogenesis, peroxisome proliferator-activated receptor (PPAR)-gamma agonists cause weight gain and hyperphagia. Given the central role of the brain in the control of energy homeostasis, we sought to determine whether PPARgamma is expressed in key brain areas involved in metabolic regulation. Using immunohistochemistry, PPARgamma distribution and its colocalization with neuron-specific protein markers were investigated in rat and mouse brain sections spanning the hypothalamus, the ventral tegmental area, and the nucleus tractus solitarius. In several brain areas, nuclear PPARgamma immunoreactivity was detected in cells that costained for neuronal nuclei, a neuronal marker. In the hypothalamus, PPARgamma immunoreactivity was observed in a majority of neurons in the arcuate (including both agouti related protein and alpha-MSH containing cells) and ventromedial hypothalamic nuclei and was also present in the hypothalamic paraventricular nucleus, the lateral hypothalamic area, and tyrosine hydroxylase-containing neurons in the ventral tegmental area but was not expressed in the nucleus tractus solitarius. To validate and extend these histochemical findings, we generated mice with neuron-specific PPARgamma deletion using nestin cre-LoxP technology. Compared with littermate controls, neuron-specific PPARgamma knockout mice exhibited dramatic reductions of both hypothalamic PPARgamma mRNA levels and PPARgamma immunoreactivity but showed no differences in food intake or body weight over a 4-wk study period. We conclude that: 1) PPARgamma mRNA and protein are expressed in the hypothalamus, 2) neurons are the predominant source of PPARgamma in the central nervous system, although it is likely expressed by nonneuronal cell types as well, and 3) arcuate nucleus neurons that control energy homeostasis and glucose metabolism are among those in which PPARgamma is expressed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845632      PMCID: PMC2646542          DOI: 10.1210/en.2008-0899

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  25 in total

1.  PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro.

Authors:  E D Rosen; P Sarraf; A E Troy; G Bradwin; K Moore; D S Milstone; B M Spiegelman; R M Mortensen
Journal:  Mol Cell       Date:  1999-10       Impact factor: 17.970

2.  Diabetes, obesity, and the brain.

Authors:  Michael W Schwartz; Daniel Porte
Journal:  Science       Date:  2005-01-21       Impact factor: 47.728

Review 3.  Retinoid x receptor heterodimers in the metabolic syndrome.

Authors:  Andrew I Shulman; David J Mangelsdorf
Journal:  N Engl J Med       Date:  2005-08-11       Impact factor: 91.245

4.  Systematic gene expression mapping clusters nuclear receptors according to their function in the brain.

Authors:  Françoise Gofflot; Nathalie Chartoire; Laurent Vasseur; Sami Heikkinen; Doulaye Dembele; Julie Le Merrer; Johan Auwerx
Journal:  Cell       Date:  2007-10-19       Impact factor: 41.582

5.  Fenofibrate and rosiglitazone lower serum triglycerides with opposing effects on body weight.

Authors:  E Chaput; R Saladin; M Silvestre; A D Edgar
Journal:  Biochem Biophys Res Commun       Date:  2000-05-10       Impact factor: 3.575

6.  Rat PPARs: quantitative analysis in adult rat tissues and regulation in fasting and refeeding.

Authors:  P Escher; O Braissant; S Basu-Modak; L Michalik; W Wahli; B Desvergne
Journal:  Endocrinology       Date:  2001-10       Impact factor: 4.736

7.  Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis.

Authors:  Aaron W Pardini; Hong T Nguyen; Dianne P Figlewicz; Denis G Baskin; Diana L Williams; Francis Kim; Michael W Schwartz
Journal:  Brain Res       Date:  2006-08-22       Impact factor: 3.252

8.  Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis.

Authors:  Evan D Rosen; Rohit N Kulkarni; Pasha Sarraf; Umut Ozcan; Terumasa Okada; Chung-Hsin Hsu; Daniel Eisenman; Mark A Magnuson; Frank J Gonzalez; C Ronald Kahn; Bruce M Spiegelman
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

9.  Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.

Authors:  A Vidal-Puig; M Jimenez-Liñan; B B Lowell; A Hamann; E Hu; B Spiegelman; J S Flier; D E Moller
Journal:  J Clin Invest       Date:  1996-06-01       Impact factor: 14.808

10.  Insulin action in AgRP-expressing neurons is required for suppression of hepatic glucose production.

Authors:  A Christine Könner; Ruth Janoschek; Leona Plum; Sabine D Jordan; Eva Rother; Xiaosong Ma; Chun Xu; Pablo Enriori; Brigitte Hampel; Gregory S Barsh; C Ronald Kahn; Michael A Cowley; Frances M Ashcroft; Jens C Brüning
Journal:  Cell Metab       Date:  2007-06       Impact factor: 27.287

View more
  74 in total

1.  The role of peroxisome proliferator-activated receptor γ in pancreatic β cell function and survival: therapeutic implications for the treatment of type 2 diabetes mellitus.

Authors:  D Gupta; T Kono; C Evans-Molina
Journal:  Diabetes Obes Metab       Date:  2010-12       Impact factor: 6.577

Review 2.  Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.

Authors:  Xiu-Rong Zhao; Nicole Gonzales; Jaroslaw Aronowski
Journal:  CNS Neurosci Ther       Date:  2014-11-28       Impact factor: 5.243

3.  Rosiglitazone improves insulin sensitivity and baroreflex gain in rats with diet-induced obesity.

Authors:  Ding Zhao; Belinda H McCully; Virginia L Brooks
Journal:  J Pharmacol Exp Ther       Date:  2012-07-18       Impact factor: 4.030

4.  Ethanol-induced changes in poly (ADP ribose) polymerase and neuronal developmental gene expression.

Authors:  David P Gavin; Handojo Kusumo; Rajiv P Sharma; Marina Guizzetti
Journal:  Neuropharmacology       Date:  2016-08-04       Impact factor: 5.250

5.  Analgesic tolerance to morphine is regulated by PPARγ.

Authors:  Giordano de Guglielmo; Marsida Kallupi; Giulia Scuppa; Serena Stopponi; Gregory Demopulos; George Gaitanaris; Roberto Ciccocioppo
Journal:  Br J Pharmacol       Date:  2014-12       Impact factor: 8.739

6.  PPARγ Agonists Attenuate Trigeminal Neuropathic Pain.

Authors:  Danielle N Lyons; Liping Zhang; Robert J Danaher; Craig S Miller; Karin N Westlund
Journal:  Clin J Pain       Date:  2017-12       Impact factor: 3.442

7.  Regulation of brain PPARgamma2 contributes to ketogenic diet anti-seizure efficacy.

Authors:  Timothy A Simeone; Stephanie A Matthews; Kaeli K Samson; Kristina A Simeone
Journal:  Exp Neurol       Date:  2016-08-12       Impact factor: 5.330

8.  A molecular mechanism for ibuprofen-mediated RhoA inhibition in neurons.

Authors:  John Dill; Ankur R Patel; Xiao-Li Yang; Robert Bachoo; Craig M Powell; Shuxin Li
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

9.  Effect of selective expression of dominant-negative PPARγ in pro-opiomelanocortin neurons on the control of energy balance.

Authors:  Madeliene Stump; Deng-Fu Guo; Ko-Ting Lu; Masashi Mukohda; Xuebo Liu; Kamal Rahmouni; Curt D Sigmund
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

Review 10.  Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  2010-04-02       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.